127 related articles for article (PubMed ID: 6895717)
41. Phase II trial of amsacrine in children with advanced metastatic neuroblastoma.
De Bernardi B; Pastore G; Garaventa A; Calculli G; Carli M; Ceci A; di Montezemolo LC; Pianca C; Romano C; Russo A
Cancer Treat Rep; 1984; 68(7-8):1051-2. PubMed ID: 6547640
[No Abstract] [Full Text] [Related]
42. Phase II study of amsacrine (AMSA) in previously treated patients with advanced transitional cell carcinoma of the urothelium: a National Bladder Cancer Collaborative Group A study.
Trump DL; Loening S; Ahmed SW; Wajsman Z
Cancer Treat Rep; 1983 Sep; 67(9):845-6. PubMed ID: 6688377
[No Abstract] [Full Text] [Related]
43. Phase I-II study of m-AMSA administered as a continuous infusion.
Micetich KC; Zwelling LA; Gormley P; Young RC
Cancer Treat Rep; 1982 Oct; 66(10):1813-7. PubMed ID: 6897013
[TBL] [Abstract][Full Text] [Related]
44. Meta AMSA (m-AMSA) in patients with advanced ovarian carcinoma.
Kearsley JH; Page JP; Levi JA; Woods RL; Tattersall MH; Fox RM; Coates AS
Aust N Z J Obstet Gynaecol; 1982 May; 22(2):107-9. PubMed ID: 6958247
[No Abstract] [Full Text] [Related]
45. A phase II trial of m-AMSA in head and neck cancer.
Forastiere AA; Young CW; Wittes RE
Cancer Chemother Pharmacol; 1981; 6(2):145-6. PubMed ID: 6895486
[TBL] [Abstract][Full Text] [Related]
46. Phase II trial of m-AMSA in gallbladder and cholangiocarcinoma: a Southwest Oncology Group Study.
Bukowski RM; Leichman LP; Rivkin SE
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):721-3. PubMed ID: 6307706
[TBL] [Abstract][Full Text] [Related]
47. AMSA: a phase II trial in resistant and recurrent acute myelogenous leukemia.
Boccia R; Zighelboim J; Champlin RE; Kim CC; Gale RP
Med Pediatr Oncol; 1984; 12(3):178-9. PubMed ID: 6587178
[TBL] [Abstract][Full Text] [Related]
48. Phase II study of amsacrine in gastric carcinoma: a southwest oncology group study.
Inamasu M; Oishi N; Chen TT; Hicks WJ; O'Bryan RM
Cancer Treat Rep; 1985 May; 69(5):557-8. PubMed ID: 3839167
[No Abstract] [Full Text] [Related]
49. AMSA and peptichemio in the treatment of advances metastatic breast cancer: a phase II study.
Buzdar AU; Legha SS; Hortobagyi GN; Powell KC; Blumenschein GR; Bodey GP
Am J Clin Oncol; 1982 Aug; 5(4):383-7. PubMed ID: 6896794
[TBL] [Abstract][Full Text] [Related]
50. Phase II study of amsacrine in metastatic renal cell carcinoma: a Cancer and Leukemia Group B study.
Amrein PC; Coleman M; Richards F; Poulin RF; Berkowitz I; Kennedy BJ; Green M; Herschkopf R; Rafla S
Cancer Treat Rep; 1983 Nov; 67(11):1043-4. PubMed ID: 6688967
[No Abstract] [Full Text] [Related]
51. A phase II study of m-AMSA in patients with primary liver cancer.
Falkson G; Coetzer B; Klaassen DJ
Cancer Chemother Pharmacol; 1981; 6(2):127-9. PubMed ID: 6895485
[TBL] [Abstract][Full Text] [Related]
52. The treatment of melanoma with m-AMSA. A Cancer and Leukemia Group B phase II study.
Amrein PC; Poulin RF; Coleman M; Richards F; Weil M; Kennedy BJ; Carey RW; Green MR; Holland JF; Weinberg V
Am J Clin Oncol; 1984 Jun; 7(3):269-71. PubMed ID: 6547269
[TBL] [Abstract][Full Text] [Related]
53. Amsacrine (AMSA) in the treatment of lymphoma.
Warrell RP
Cancer Treat Rep; 1983 Mar; 67(3):320-1. PubMed ID: 6687561
[No Abstract] [Full Text] [Related]
54. Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group.
De Jager R; Siegenthaler P; Cavalli F; Klepp O; Bramwell V; Joss R; Alberto P; van Glabbeke M; Renard J; Rozencweig M; Hansen HH
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):289-93. PubMed ID: 6687457
[TBL] [Abstract][Full Text] [Related]
55. A phase II study of m-AMSA in patients with malignant mesothelioma.
Falkson G; Vorobiof DA; Lerner HJ
Cancer Chemother Pharmacol; 1983; 11(2):94-7. PubMed ID: 6688764
[TBL] [Abstract][Full Text] [Related]
56. m-AMSA: a review of clinical data.
Zittoun R
Eur J Cancer Clin Oncol; 1985 Jun; 21(6):649-53. PubMed ID: 3894030
[No Abstract] [Full Text] [Related]
57. m-AMSA and adenocarcinoma of the endometrium. A Southwest Oncology Group study.
Hilgers RD; Legha SS; Johnston GA; Alberts DS; Stephens RL; Tranum BL; Hannigan EV
Invest New Drugs; 1984; 2(3):335-8. PubMed ID: 6548984
[TBL] [Abstract][Full Text] [Related]
58. Phase II study of m-AMSA in advances malignant melanoma.
Arseneau JC; Wolter JM; Probert JC; Kuperminc M
Am J Clin Oncol; 1982 Aug; 5(4):433-6. PubMed ID: 6896795
[TBL] [Abstract][Full Text] [Related]
59. Phase II evaluation of AMSA in patients with stage III--IV malignant melanoma.
Fuks JZ; Van Echo DA; Aisner J; Schipper H; Levitt M; Wiernik PH
Cancer Treat Rep; 1982 May; 66(5):1237-8. PubMed ID: 7083226
[No Abstract] [Full Text] [Related]
60. m-AMSA in epithelial carcinoma of the ovary. A Southwest Oncology Group study.
Hilgers RD; Legha SS; Panettiere FJ; Alberts DS
Am J Clin Oncol; 1983 Jun; 6(3):277-9. PubMed ID: 6687779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
